CUTANEOUS T CELL LYMPHOMA
Clinical trials for CUTANEOUS T CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS T CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS T CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cream targets skin lymphoma without steroids
Disease control Not yet recruitingThis study tests a cream called benvitimod (tapinarof) for people with cutaneous T-cell lymphoma, a rare skin cancer that causes red patches and itching. The cream is non-steroidal and works by targeting a specific receptor in skin cells. About 35 adults with the disease will app…
Matched conditions: CUTANEOUS T CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a spray alter skin bacteria to help lymphoma lesions?
Disease control Not yet recruitingThis early-stage study tests a wound spray (APR-TD011) on skin lesions caused by cutaneous T cell lymphoma. Researchers want to see if the spray can reduce harmful bacteria (Staphylococcus aureus) on the skin and if it is well tolerated. The study will include 30 adults with earl…
Matched conditions: CUTANEOUS T CELL LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC